Norvatis expands Africa Sickle Cell Disease program to East Africa

EAST AFRICA – Novartis, a global healthcare company, and its partners have announced the expansion of the Africa Sickle Cell Disease program to East Africa with the signature of two new memoranda of understanding with the Ministries of Health of Uganda and Tanzania.   The partners intend to develop and implement a comprehensive approach that includes making diagnosis and treatment available, accessible and affordable for patients and their families; promoting scientific research, training and education; and pursuing robust monitoring and evaluation of the program.   As a next step, Novartis plans…

Read More